Literature DB >> 8646148

Lessons from international experience in controlling pharmaceutical expenditure. II: Influencing doctors.

K Bloor1, N Freemantle.   

Abstract

This is the second of three papers that review international policies to control spending on drugs and to improve the efficiency of drug use. This paper reviews policies influencing doctors' prescribing of drugs--particularly the use of budgetary restrictions, information and feedback, and guidelines--and evaluates the impact of these policies. Studies evaluating incentive systems are limited, but evidence suggests that providing information on its own will not lead to substantial changes in practice and that more active strategies should be evaluated.

Mesh:

Substances:

Year:  1996        PMID: 8646148      PMCID: PMC2351250          DOI: 10.1136/bmj.312.7045.1525

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  10 in total

1.  The New Zealand preferred medicines concept: a national scheme for audit and quality assurance of prescribing.

Authors:  T J Maling
Journal:  Pharmacoeconomics       Date:  1994-07       Impact factor: 4.981

2.  New developments in pricing and drug reimbursement in France.

Authors:  A Pelc; J P Castan
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

3.  Principles of educational outreach ('academic detailing') to improve clinical decision making.

Authors:  S B Soumerai; J Avorn
Journal:  JAMA       Date:  1990-01-26       Impact factor: 56.272

4.  Effect of fundholding and indicative prescribing schemes on general practitioners' prescribing costs.

Authors:  J Bradlow; A Coulter
Journal:  BMJ       Date:  1993-11-06

5.  Introducing a market to the United Kingdom's National Health Service.

Authors:  A Maynard; K Bloor
Journal:  N Engl J Med       Date:  1996-02-29       Impact factor: 91.245

6.  The effects of fundholding in general practice on prescribing habits three years after introduction of the scheme.

Authors:  S Stewart-Brown; R Surender; J Bradlow; A Coulter; H Doll
Journal:  BMJ       Date:  1995-12-09

7.  The German health care system at the crossroads.

Authors:  J M vd Schulenburg
Journal:  Health Econ       Date:  1994 Sep-Oct       Impact factor: 3.046

8.  Subcortical dementia.

Authors:  F J Dunne
Journal:  BMJ       Date:  1993-07-03

9.  Motivation for hepatitis B vaccine acceptance among medical and physician assistant students.

Authors:  D J Diekema; K J Ferguson; B N Doebbeling
Journal:  J Gen Intern Med       Date:  1995-01       Impact factor: 5.128

10.  Effect of government and commercial warnings on reducing prescription misuse: the case of propoxyphene.

Authors:  S B Soumerai; J Avorn; S Gortmaker; S Hawley
Journal:  Am J Public Health       Date:  1987-12       Impact factor: 9.308

  10 in total
  21 in total

Review 1.  Prescription data as a tool in pharmacotherapy audit (I). General considerations.

Authors:  C S de Vries; T F Tromp; W Blijleven; L T de Jong-van den Berg
Journal:  Pharm World Sci       Date:  1999-04

2.  Changing doctor prescribing behaviour.

Authors:  P S Gill; M Mäkelä; K M Vermeulen; N Freemantle; G Ryan; C Bond; T Thorsen; F M Haaijer-Ruskamp
Journal:  Pharm World Sci       Date:  1999-08

3.  Mega-mergers in the pharmaceutical industry. In whose interests?

Authors:  A L Po
Journal:  Pharmacoeconomics       Date:  1998-10       Impact factor: 4.981

Review 4.  Drug rationing in the UK National Health Service. Current status and future prospects.

Authors:  T Walley; A Haycox; S Barton
Journal:  Pharmacoeconomics       Date:  1997-09       Impact factor: 4.981

Review 5.  Pharmacy utilization and the Medicare Modernization Act.

Authors:  Vittorio Maio; Laura Pizzi; Adam R Roumm; Janice Clarke; Neil I Goldfarb; David B Nash; David Chess
Journal:  Milbank Q       Date:  2005       Impact factor: 4.911

6.  Responding to the evidence: Evidence-based implementation of evidence-based medicine.

Authors:  C W Onion
Journal:  Occas Pap R Coll Gen Pract       Date:  2001-07

7.  French regulatory medical references are criteria, not clinical guidelines.

Authors:  H Maisonneuve; C Colin; Y Matillon
Journal:  BMJ       Date:  1996-09-28

Review 8.  Pricing and reimbursement of pharmaceuticals. A new culture for the community pharmacist.

Authors:  E Moen; E L Toverud; J Grund; S Brinchmann
Journal:  Pharm World Sci       Date:  1998-06

9.  Controversies in primary care. Setting prescribing budgets in general practice. Capitation based prescribing budgets will not work.

Authors:  A Majeed; S Head
Journal:  BMJ       Date:  1998-03-07

10.  Drug reimbursement: indicators of inappropriate resource allocation.

Authors:  Bernard Bégaud; Ulf Bergman; Hans-Georg Eichler; Hubert G M Leufkens; Peter J Meier
Journal:  Br J Clin Pharmacol       Date:  2002-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.